anmelden
OMX Nordic 40
2.687,50
PKT
+3,93
PKT
+0,15
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu OMX Nordic 40-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 10.10.17 | Nokia buy | UBS AG | |
| 10.10.17 | ABB (Asea Brown Boveri) Hold | Deutsche Bank AG | |
| 10.10.17 | Novo Nordisk Reduce | HSBC | |
| 09.10.17 | Volvo (B) Underweight | Morgan Stanley | |
| 09.10.17 | AstraZeneca Neutral | UBS AG | |
| 09.10.17 | Novo Nordisk buy | Goldman Sachs Group Inc. | |
| 09.10.17 | AstraZeneca Reduce | HSBC | |
| 06.10.17 | Fortum Neutral | JP Morgan Chase & Co. | |
| 05.10.17 | Nokia overweight | Morgan Stanley | |
| 05.10.17 | ABB (Asea Brown Boveri) Equal-Weight | Morgan Stanley | |
| 03.10.17 | Ericsson (Telefon L.M.Ericsson) (B) Underperform | Credit Suisse Group | |
| 02.10.17 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
| 02.10.17 | Fortum Outperform | Macquarie Research | |
| 29.09.17 | Fortum Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 28.09.17 | Fortum Hold | S&P Capital IQ | |
| 27.09.17 | Fortum Reduce | Kepler Cheuvreux | |
| 27.09.17 | Nokia buy | Société Générale Group S.A. (SG) | |
| 26.09.17 | ABB (Asea Brown Boveri) Sell | Citigroup Corp. | |
| 26.09.17 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
| 26.09.17 | ABB (Asea Brown Boveri) Neutral | Goldman Sachs Group Inc. | |
| 25.09.17 | AstraZeneca Outperform | BNP PARIBAS | |
| 25.09.17 | Novo Nordisk Neutral | BNP PARIBAS | |
| 25.09.17 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
| 22.09.17 | Nokia Underperform | BNP PARIBAS | |
| 22.09.17 | AstraZeneca Outperform | Bernstein Research | |
| 19.09.17 | Nokia buy | UBS AG | |
| 19.09.17 | AstraZeneca buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 18.09.17 | AstraZeneca Hold | Jefferies & Company Inc. | |
| 18.09.17 | Novo Nordisk Hold | Jefferies & Company Inc. | |
| 14.09.17 | Nokia buy | Goldman Sachs Group Inc. | |
| 13.09.17 | AstraZeneca overweight | Barclays Capital | |
| 13.09.17 | Novo Nordisk Underweight | JP Morgan Chase & Co. | |
| 13.09.17 | AstraZeneca Neutral | JP Morgan Chase & Co. | |
| 13.09.17 | ABB (Asea Brown Boveri) Hold | Deutsche Bank AG | |
| 12.09.17 | Volvo (B) Neutral | UBS AG | |
| 11.09.17 | AstraZeneca Neutral | UBS AG | |
| 11.09.17 | AstraZeneca Hold | Jefferies & Company Inc. | |
| 11.09.17 | AstraZeneca Neutral | BNP PARIBAS | |
| 11.09.17 | AstraZeneca buy | Citigroup Corp. | |
| 11.09.17 | AstraZeneca buy | Deutsche Bank AG |
